Skip to content
AI Health Assistant

CA 125 Test in Bangalore

About the CA 125 Test

The CA 125 Test (Cancer Antigen 125 Test) measures CA 125 protein levels in blood, helping doctors screen for ovarian cancer and monitor treatment response in women. This essential diagnostic test helps doctors detect ovarian cancer early, monitor ovarian cancer treatment effectiveness, assess treatment response, detect cancer recurrence, evaluate pelvic masses, differentiate benign from malignant ovarian cysts, screen high-risk women, assess uterine cancer risk, monitor endometrial cancer, evaluate breast cancer spread, detect peritoneal cancer, assess pancreatic cancer extent, monitor tubal cancer, guide treatment decisions, and evaluate unexplained abdominal symptoms. CA 125 is a tumor marker produced by ovarian cancer cells and some normal tissues. Doctors typically recommend this test for women with pelvic mass or abdominal swelling, unexplained abdominal pain, bloating or fullness, irregular vaginal bleeding, postmenopausal bleeding, family history of ovarian cancer, known ovarian cancer monitoring, after ovarian cancer treatment, pelvic exam abnormalities, ultrasound showing ovarian cyst, abdominal bloating lasting >2 weeks, difficulty eating, urinary symptoms, or weight loss with abdominal symptoms. Elevated CA 125 indicates ovarian cancer or benign conditions requiring further evaluation. With Seviyaar, patients in Bangalore can access the CA 125 Test through NABL-certified laboratories ensuring accurate and reliable results. You can book your test using the lab tests booking platform and receive timely digital reports for better healthcare management in Bangalore efficiently.
Book Now

How Seviyaar Can Help

Booking a CA 125 Test in Bangalore is simple with Seviyaar’s user-friendly platform. Patients can schedule tests online, choose home blood sample collection with trained phlebotomists, and receive accurate digital reports typically by the next day within 24 hours from NABL-certified labs. The platform ensures reliable diagnostics through NABL-certified partner labs while also offering access to online doctor consultations for result interpretation and gynecology cancer guidance. Additionally, users can explore supportive homecare services for ongoing medical needs, making healthcare more accessible and efficient for Bangalore residents.
Book Now

FAQ

The CA 125 Test measures CA 125 tumor marker to detect ovarian cancer early, monitor ovarian cancer treatment effectiveness, assess treatment response, detect cancer recurrence, evaluate pelvic masses, differentiate benign from malignant ovarian cysts, screen high-risk women, and monitor gynecological cancers.

Yes, you can easily book the CA 125 Test online through Seviyaar with home blood sample collection available. Reports are delivered digitally by the next day within 24 hours through Seviyaar's platform from NABL-certified partner labs.

No, fasting is not required for the CA 125 Test. You can eat and drink normally. The test requires a blood sample from the vein, collected by a trained phlebotomist. Women should avoid scheduling during menstruation as it can elevate CA 125 levels.

Doctors recommend for women with pelvic mass or abdominal swelling, unexplained abdominal pain, bloating lasting >2 weeks, irregular Vaginal bleeding, postmenopausal bleeding, family history of ovarian cancer, known ovarian cancer monitoring, pelvic exam abnormalities, ultrasound showing ovarian cyst, difficulty eating, urinary symptoms, or weight loss.

CA 125 Test results are typically available by the next day within 24 hours after sample collection. Reports are conveniently delivered digitally through Seviyaar's platform with notifications for quick gynecologist consultation and cancer management.

CA 125 Test results are quantitative (measured in U/mL): Normal: <35 U/mL (normal for most women). Elevated: >35 U/mL indicates possible ovarian cancer or benign conditions. Moderately elevated (35-100 U/mL): May indicate benign conditions (endometriosis, fibroids, PID, menstruation, pregnancy) or early cancer. Highly elevated (>100 U/mL): Strongly suggests ovarian cancer. Postmenopausal women with >35 U/mL have higher cancer risk. Your report includes reference values with interpretation guidelines.

The CA 125 Test detects ovarian cancer (epithelial), ovarian cancer recurrence after treatment, ovarian cancer treatment monitoring, uterine/endometrial cancer, fallopian tube cancer, primary peritoneal cancer, pancreatic cancer with peritoneal spread, breast cancer metastasis, lung cancer peritoneal spread, endometriosis, uterine fibroids, pelvic inflammatory disease, ovarian cysts (benign), pregnancy-related elevation, menstrual cycle elevation, liver cirrhosis, ascites, pleural effusion, and differentiates malignant from benign pelvic masses for appropriate oncology/gynecology management and treatment planning.